Who Paid My Doc
Kanuma
Biological Rare Disease
NDC 25682-007-01
General payments
$525,096
Research payments
$969,026
Through program year 2025, $525,096 in general payments and $969,026 in research payments were reported against Kanuma (Rare Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,945 | 8 |
| 2025 | Research | $189,808 | 39 |
| 2024 | General | $8,666 | 11 |
| 2024 | Research | $475,162 | 53 |
| 2023 | General | $505,250 | 7 |
| 2023 | Research | $149,023 | 29 |
| 2022 | General | $4,235 | 10 |
| 2022 | Research | $155,034 | 34 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
36 general · 155 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.